Atnaujinkite slapukų nuostatas

El. knyga: Cancer Epigenetics and Nanomedicine: Targeting the Right Player via Nanotechnology

4.00/5 (2 ratings by Goodreads)
Edited by (Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India), Edited by (Research Assistant Professor, Stony Brook Cancer Center, Stony Brook University, New York, United States of America)
  • Formatas: 550 pages
  • Išleidimo metai: 26-Jun-2024
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780443132100
Kitos knygos pagal šią temą:
Cancer Epigenetics and Nanomedicine: Targeting the Right Player via NanotechnologyDidesnis paveikslėlis
  • Formatas: 550 pages
  • Išleidimo metai: 26-Jun-2024
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780443132100
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Cancer Epigenetics and Nanomedicine: Targeting the Right Player via Nanotechnology is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.

Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.

Overview of Cancer, Internal and External Factors Associated with Cancer
1. Overview of Cancer: Mechanism of Carcinogenesis Uttara Saran and Chitra Thakur
2. Tumor metabolism and micro-nutrients: New insights to target malignant tumors Santhi Latha Pandrangi, Sireesha V. Garimella, and Prasanthi Chittineedi
3. Inflammation and cancer: An insight Suchandrima Saha, Monisankar Ghosh
4. Environmental Causes of Cancer Priya Wadgaonkar
5. Cancer stem cells: challenges for cancer therapies Rashi Arora and Apoorva Uboveja
6. Carving a therapeutic niche for metastatic cancer: opportunities and challenges Sireesha V. Garimella Epigenetics and its Importance in Cancer Therapies
7. An overview on the epigenetics and cancer Rajendra Prasad Pangeni
8. Causes and Consequences of Variable Tumor Microenvironment on Tumor Evolution Jowana Obeid and Mehdi Damaghi
9. Understanding epigenetics in cancer stem cells and chemoresistance Prajakta Oak and Chitra Thakur
10. Cancer Biomarkers: Where Genetics Meets Epigenetics Snehal Nirgude, Jennifer M. Kalish
11. Epigenetics Approach in Cancer Treatment with Focus on Lung and Breast Cancer Sayani Bhattacharjee
12. Epigenetic diets and drugs in cancer prevention and treatment Chitra Thakur and Uttara Saran Nanomedicine Targeting Epigenetic Machinery in Cancer Therapy
13. Nanotechnology and its relevance in cancer therapies Nur Khatijah Mohd Zin 14 Epigenetic modulation by biosynthetic nanomaterials from plants in cancer Ritu Karwasra 15 Nanotechnology augmented Immunotherapy for cancer Akshata R. Naik 16 Nanoparticles in metastatic cancer treatment Prashant Kesharwani 17 Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer Somaye Akbari, Yeganeh Modirrousta
18. Nanomedicine and Epigenome: possible health risks, benefits, and future Nitin Verma
29. Smart Cancer Nanomedicine: Challenges and Future Opportunities Moumita Roy

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as USERN Laureate award”, most prestigious SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

Dr. Chitra Thakur is an Assistant Professor-Research in the Department of Pathology at the Stony Brook Cancer Center, New York, USA. She is a cancer biologist and has expertise in molecular oncology, mouse models of human cancers, analyzing big data in translational research, toxicology, and epigenetics in human cancers. She is the recipient of several internationally acclaimed awards such as the DFG German Excellence Initiative Award,”, NIH-Big Data Training for Translational Omics Research” and American Cancer Society IRG”. With more than 45 research articles published in mainstream scientific journals, she has contributed significantly towards the understanding of the molecular mechanisms in human cancers. She is engrossed in cancer research, teaching, and community outreach initiatives, hence fostering the scientific community and health care professionals engaged in cancer diagnosis, and treatment.
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97804431321002e.html